|
TMEM33 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.296200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.874400E-01 |
| Normal-vs-Stage2 |
3.656800E-01 |
| Normal-vs-Stage3 |
9.757200E-01 |
| Normal-vs-Stage4 |
6.762000E-01 |
| Stage1-vs-Stage2 |
4.570400E-01 |
| Stage1-vs-Stage3 |
5.858600E-01 |
| Stage1-vs-Stage4 |
3.755400E-01 |
| Stage2-vs-Stage3 |
3.309600E-01 |
| Stage2-vs-Stage4 |
2.046200E-01 |
| Stage3-vs-Stage4 |
6.943000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.749400E-01 |
| Normal-vs-AfricanAmerican |
2.994200E-01 |
| Normal-vs-Asian |
6.563400E-01 |
| Caucasian-vs-AfricanAmerican |
2.527800E-01 |
| Caucasian-vs-Asian |
6.280400E-01 |
| AfricanAmerican-vs-Asian |
1.705160E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.296000E-01 |
| Normal-vs-Female |
6.677400E-01 |
| Male-vs-Female |
6.427800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.527200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.624400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.957400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.487400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.097200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.700200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.618200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.837410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.992800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.703600E-01 |
| Classical-VS-Follicular |
4.181400E-01 |
| Classical-VS-Other |
2.371200E-01 |
| Classical-VS-Normal |
5.820800E-01 |
| Tall-VS-Follicular |
3.686200E-01 |
| Tall-VS-Other |
3.796200E-01 |
| Tall-VS-Normal |
9.124600E-01 |
| Follicular-VS-Other |
2.149600E-01 |
| Follicular-VS-Normal |
3.365200E-01 |
| Other-VS-Normal |
3.368200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.598800E-01 |
| Normal-vs-N1 |
2.278400E-01 |
| N0-vs-N1 |
1.052040E-01 |
|
|
